Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Icatibant in Knee Osteoarthritis
NCT00303056Phase 2Completed
- Sponsor
- Sanofi
- Start
- Feb 2006
- Primary completion
- Jul 2007
- Modality
- Peptides, Small Molecules
- Countries
- 5
01
Overview
Phase 2, randomised, double-blind trial of icatibant in osteoarthritis (OA) (3 arms), sponsored by Sanofi. Primary endpoint: Pain during activity, at rest and at night. Started Feb 2006; status: completed.
02
Drugs
icatibant
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT00303056.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00303056.